SlideShare a Scribd company logo
1 of 41
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis CompanyCopyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
Chapter Sixteen
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
Figure 16-1
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
 Because the components of the humoral and
cell-mediated portions of the immune system
interact extensively through many regulatory
and effector loops, a defect in one arm of the
system may affect other aspects of immune
function as well.
 With the exception of IgA deficiency,
primary immunodeficiency syndromes are
rare.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
 A deficiency of one component of the system is
often accompanied by hyperactivity of other
component, including allergic or autoimmune
manifestations.
 More than 120 different congenital forms of
immunodeficiency have been reported, including
defects in lymphoid cells, phagocytic cells, and
complement proteins. Some are X-linked; some
are autosomal recessive. When NK cells are
reduced, there is a higher rate of malignancy.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
 The clinical symptoms associated with immune
deficiencies range from very mild or subclinical to
severe recurrent infections or failure to thrive.
 In general, defects in humoral immunity result in
pyogenic bacterial infections, particularly of the
upper and lower respiratory tract.
 Complement deficiencies result in recurrent
bacterial infections and autoimmune problems.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
 Defects in T-cell-mediated immunity result in
recurrent infections with intracellular
pathogens such as viruses, fungi, and
intracellular bacteria.
 These patients are also prone to
disseminated viral infections, especially with
latent viruses such as herpes simplex,
varicella zoster, and cytomegalovirus.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
 The mechanisms of the agammaglobulinemias
include genetic defects in B-cell maturation or
mutations leading to defective interactions
between B and T cells.
 Only the more common and well-characterized
syndromes are described here and are
summarized in Table 16-1.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
 In evaluating immunoglobulin deficiency
states, it is important to remember that blood
levels of immunoglobulins change with
age.
 IgM reaches normal adult levels first, around 1
year of age, followed by IgG at about 5 to 6
years of age.
 In some normal children, IgA levels do not
reach normal adult values until adolescence.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – THI
 All infants experience low levels of
immunoglobulins at approximately 5 to 6
months of age, but in some cases, the low
levels persist for a longer time.
 Transient hypogammaglobulinemia of
infancy may result.
 The mechanism of this transient
hypogammaglobulinemia is not known.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – BA
 Bruton’s agammaglobulinemia, first
described in 1952, is X chromosome–linked,
and so affects males almost exclusively.
 Patients with X-linked agammaglobulinemia
lack circulating mature CD19 positive B cells
and exhibit a deficiency or lack of
immunoglobulins of all classes.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – BA
 Patients have no plasma cells in their
lymphoid tissues, but they do have pre-B cells
in their bone marrow.
 T cells are normal in number and function.
 These patients develop recurrent bacterial
infections beginning in infancy, as maternal
antibody is cleared.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – BA
 X-linked hypogammaglobulinemia results from
arrested differentiation at the pre-B cell stage,
leading to a complete absence of mature B
cells and plasma cells.
 The underlying genetic mechanism is a
deficiency of an enzyme called the Bruton
tyrosine kinase (Btk) in B-cell progenitor cells.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – BA
 Lack of the Btk enzyme apparently causes a
failure of Vh gene rearrangement.
 The syndrome can be differentiated from
transient hypogammaglobulinemia of infancy
by the absence of CD19 positive B cells in the
peripheral blood, by the abnormal histology of
lymphoid tissues, and by its persistence
beyond 2 years of age.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – IgA Def
 Most patients with IgA deficiency are
asymptomatic. This is the most common
congenital immune deficiency and appears to
be a failure in isotype switching in B cells.
 Those patients with symptoms usually have
infections of the respiratory and
gastrointestinal tract and an increased
tendency to autoimmune diseases and
allergies
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – CVI
 Common variable immunodeficiency (CVI)
is a heterogeneous group of disorders ,
leading to IgG and IgA deficiencies
 The disorder can be congenital or acquired,
familial or sporadic, and it occurs with equal
frequency in men and women.
 leads to recurrent bacterial infections,
particularly sinusitis and pneumonia.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – CVI
 In contrast to X-linked agammaglobulinemia,
most patients with CVI have normal numbers
of mature B cells, but they fail to transform into
plasma cells.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
 Defects in cell-mediated immunity can
result from abnormalities at many different
stages of T-cell development.
 In some cases, a primary defect in cell-
mediated immunity can also have secondary
effects on humoral immunity.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – DGA
 The immunodeficiency associated with the
DiGeorge anomaly is a quantitative defect in
thymocytes due to a developmental defect in
the thymus.
 Insufficient mature T cells are made, but those
that are present are functionally normal. May
undergo bone marrow or thymus transplant.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
 Defects in both humoral (B cell) and cell-
mediated (T cell) immunity can be caused
by a defect that affects development of both
types of lymphocytes or a defective interaction
between the two limbs of the immune system.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – SCID
 The most serious of the congenital immune
deficiencies is severe combined
immunodeficiency (SCID).
 SCID is actually a group of related diseases
that all affect T- and B-cell function but with
differing causes.
 X-linked SCID is the most common form of the
disease, presenting in early infancy with
multiple types of infections.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – SCID
 The abnormal gene involved codes for a
protein chain called the common gamma
chain, which is common to receptors for
interleukins 2, 4, 7, 9, 15, and 21.
 The gene is referred to as the IL2RG gene
and is located on the X chromosome.
 Normal signaling cannot occur in cells with
defective receptors, thus halting proliferation
and maturation.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
 Chronic granulomatous disease (CGD) is a
group of disorders inherited as either an X-
linked or autosomal recessive gene that
affects neutrophil microbicidal function.
 X-linked disease accounts for 70 percent of
the cases, and it tends to be more severe.
 CGD is the most common and best
characterized of the neutrophil
abnormalities.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – CGD
 There are three different autosomal recessive
genes involved, and all of these affect subunits
of nicotinamide adenine dinucleotide
phosphate (NADPH) oxidase.
 Normally, neutrophil stimulation leads to the
production of reactive oxygen molecules, such
as hydrogen peroxide (H2O2), by NADPH
oxidase on the plasma membrane.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – CGD
 Neutrophil granules fuse with, and release
their contents into, the forming phagosome, as
organisms are phagocytized.
 Hydrogen peroxide is then used by the granule
enzyme myeloperoxidase to generate the
potent microbicidal agent hypochlorous acid.
 In CGD, neutrophils are unable to undergo the
oxidative burst.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – CGD
 CGD was historically diagnosed by measuring
the ability of a patient’s neutrophils to reduce
the dye nitro-blue tetrazolium (NBT).
 More recently, a flow cytometric assay has
become available.
 Patients have a deficiency in G6PD for
hydrogen peroxide production, or
myeloperoxidase activity for hypochlorite
production
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – NGDD
 Even if microbicidal activity is normal,
neutrophils cannot perform their functions
properly if they fail to leave the vasculature
and migrate to a site of incipient infection.
 Adhesion receptors on leukocytes (integrins)
and their counter-receptors on endothelial
cells (selectins) and extracellular matrix play
important roles in these activities.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases
 In leukocyte adhesion deficiency (LAD), a
protein (CD18) that is a component of
adhesion receptors on neutrophils and
monocytes (with CD11b or CD11c) and on T
cells (with CD11a) is defective.
 This defect leads to abnormal adhesion,
motility, aggregation, chemotaxis, and
endocytosis by the affected leukocytes.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Diseases – LAD
 The defects are clinically manifested as
delayed wound healing, chronic skin
infections, intestinal and respiratory tract
infections, and periodontitis.
 A defect in CD18 can be diagnosed by
detecting a decreased amount of the CD11/18
antigen on patient leukocytes by flow
cytometry.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
 Deficiencies in each of the major
complement components have been
described, leading to various clinical
sequelae.
 Deficiencies in the early complement
components, C1q, 4, and 2, are usually
associated with a lupus-like syndrome.
 Deficiency of C2 is believed to be the most
common complement component deficiency.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
 A C3 deficiency may also have a lupus-like
clinical presentation but is more likely to
involve recurrent encapsulated organism
infection.
 Deficiencies of the later components of
complement (C5–C9) are often associated
with recurrent Neisseria meningitidis
infections.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
 Screening tests used for the initial
evaluation of suspected immunodeficiency
states are summarized in Table 16-3.
 Measurement of the levels of serum IgG, IgM,
and IgA and levels of the subclasses of IgG
are used to screen for defects in antibody
production.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
 An overall assessment of antibody-mediated
immunity can be made by measuring antibody
responses to antigens to which the population
is exposed normally or following vaccination.
 Delayed-hypersensitivity-type skin reactions
can be used to screen for defects in cell-
mediated immunity.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
 Screening for complement deficiencies
usually begins with a CH50 assay to
determine the level of functional complement
in an individual.
 See Chapter 6 for details of the CH50 assay.
 Defects in neutrophil oxidative burst
activity may be detected by a flow cytometric
assay, as mentioned earlier.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
 If the screening tests detect an abnormality
or if the clinical suspicion is high, more
specialized testing will probably be
necessary to precisely identify an immune
abnormality.
 Some of the tests used for confirming an
immunodeficiency state are summarized in
Table 16-4.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
 Enumeration of classes of lymphocytes in the
peripheral blood, bone marrow, and lymph
nodes is performed by flow cytometry.
 For example, an absence or profound
decrease in the number of CD3 positive cells
would be consistent with DiGeorge syndrome.
 An absence of CD19 positive B cells suggests
Bruton’s agammaglobulinemia.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
 Genetic testing is available for many
conditions, including the DiGeorge deletion,
the Wiskott-Aldrich gene, and the IL2RG
mutations in SCID.
 T-cell function can be measured by
assessing the ability of isolated T cells to
proliferate in response to an antigenic stimulus
or to nonspecific mitogens in culture.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
 Quantitative measurement of serum or
urine immunoglobulins by protein
electrophoresis is used in the workup of both
immunodeficiency states and some
lymphoproliferative disorders.
 Protein electrophoresis allows reproducible
separation of the major plasma proteins (see
Chapter 4 for details).
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
 Additional evaluation of serum immunoglobulin
is performed if the SPE shows a monoclonal
component or if there is a significant
quantitative abnormality of serum
immunoglobulins.
 Another method of characterizing immune
deficiencies is immunofixation
electrophoresis (IFE).
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
 Polyclonal immunoglobulins are indicated by
areas of diffuse staining, while monoclonal
bands produce narrow, intensely stained
bands.
 Lack of bands indicates immunodeficiencies of
one or more immunoglobulin classes.
 Refer to Figure 15-2 in Chapter 15 for
details regarding immunofixation.
 See Figure 16-2 for further examples of IF.
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
Figure 16-2
Clinical Immunology & Serology
A Laboratory Perspective, Third Edition
Copyright © 2010 F.A. Davis Company
Immunodeficiency Disease
 Specific immunoglobulin isotype levels
can be determined by nephelometry.
 A bone marrow aspirate and biopsy is
indicated in any evaluation of monoclonal
gammopathy or immunodeficiency state.

More Related Content

What's hot

B - cell Deficiency
B - cell DeficiencyB - cell Deficiency
B - cell DeficiencySaranraj P
 
Common variable immunodeficiency
Common variable immunodeficiencyCommon variable immunodeficiency
Common variable immunodeficiencyFatima Awadh
 
Tumor immunology dr. ihsan alsaimary
Tumor immunology  dr. ihsan alsaimaryTumor immunology  dr. ihsan alsaimary
Tumor immunology dr. ihsan alsaimarydr.Ihsan alsaimary
 
Immunodeficiency Syndromes: Part One: Primer on Immunology
Immunodeficiency Syndromes: Part One: Primer on ImmunologyImmunodeficiency Syndromes: Part One: Primer on Immunology
Immunodeficiency Syndromes: Part One: Primer on ImmunologyPediatric Home Service
 
Parasitic infection and immunomodulation: A possible explanation for the hygi...
Parasitic infection and immunomodulation: A possible explanation for the hygi...Parasitic infection and immunomodulation: A possible explanation for the hygi...
Parasitic infection and immunomodulation: A possible explanation for the hygi...Apollo Hospitals
 
Immunity against Helminths:role of Interleukins
Immunity against Helminths:role of InterleukinsImmunity against Helminths:role of Interleukins
Immunity against Helminths:role of InterleukinsIshfaq Maqbool
 
Immunodeficiency diseases
Immunodeficiency diseasesImmunodeficiency diseases
Immunodeficiency diseasesRAJESH KUMAR
 
Tumor immunology
Tumor immunologyTumor immunology
Tumor immunologyPashon Hana
 
Innate immune response
Innate immune responseInnate immune response
Innate immune responseReyam Ahmed
 
Pathophysiology- Global Overview of Select Infectious Diseases
Pathophysiology- Global Overview  of Select Infectious DiseasesPathophysiology- Global Overview  of Select Infectious Diseases
Pathophysiology- Global Overview of Select Infectious DiseasesImhotep Virtual Medical School
 
Immunology of tanslanatation and malignancy
Immunology of tanslanatation and malignancyImmunology of tanslanatation and malignancy
Immunology of tanslanatation and malignancyraghunathp
 
7. immunodeficiency syndromes
7. immunodeficiency syndromes7. immunodeficiency syndromes
7. immunodeficiency syndromesNkosinathiManana2
 
Immunopathology lecture 2+3 ,final
Immunopathology lecture 2+3 ,finalImmunopathology lecture 2+3 ,final
Immunopathology lecture 2+3 ,finalدكتور مريض
 
Autoimmunity and autoimmune disease
Autoimmunity and autoimmune diseaseAutoimmunity and autoimmune disease
Autoimmunity and autoimmune diseaseRhondene Wint
 

What's hot (20)

B - cell Deficiency
B - cell DeficiencyB - cell Deficiency
B - cell Deficiency
 
Immunodeficiency syndromes part 2
Immunodeficiency syndromes   part 2Immunodeficiency syndromes   part 2
Immunodeficiency syndromes part 2
 
Immunopathology 2
Immunopathology 2Immunopathology 2
Immunopathology 2
 
Primary immunodeficiencies
Primary immunodeficienciesPrimary immunodeficiencies
Primary immunodeficiencies
 
Common variable immunodeficiency
Common variable immunodeficiencyCommon variable immunodeficiency
Common variable immunodeficiency
 
Tumor immunology dr. ihsan alsaimary
Tumor immunology  dr. ihsan alsaimaryTumor immunology  dr. ihsan alsaimary
Tumor immunology dr. ihsan alsaimary
 
Basics of Immunity
Basics of ImmunityBasics of Immunity
Basics of Immunity
 
Immunodeficiency Syndromes: Part One: Primer on Immunology
Immunodeficiency Syndromes: Part One: Primer on ImmunologyImmunodeficiency Syndromes: Part One: Primer on Immunology
Immunodeficiency Syndromes: Part One: Primer on Immunology
 
Parasitic infection and immunomodulation: A possible explanation for the hygi...
Parasitic infection and immunomodulation: A possible explanation for the hygi...Parasitic infection and immunomodulation: A possible explanation for the hygi...
Parasitic infection and immunomodulation: A possible explanation for the hygi...
 
Immunity against Helminths:role of Interleukins
Immunity against Helminths:role of InterleukinsImmunity against Helminths:role of Interleukins
Immunity against Helminths:role of Interleukins
 
Hyper IgM Syndrome
Hyper IgM SyndromeHyper IgM Syndrome
Hyper IgM Syndrome
 
Immunodeficiency diseases
Immunodeficiency diseasesImmunodeficiency diseases
Immunodeficiency diseases
 
Tumor immunology
Tumor immunologyTumor immunology
Tumor immunology
 
Innate immune response
Innate immune responseInnate immune response
Innate immune response
 
Pathophysiology- Global Overview of Select Infectious Diseases
Pathophysiology- Global Overview  of Select Infectious DiseasesPathophysiology- Global Overview  of Select Infectious Diseases
Pathophysiology- Global Overview of Select Infectious Diseases
 
Immunology of tanslanatation and malignancy
Immunology of tanslanatation and malignancyImmunology of tanslanatation and malignancy
Immunology of tanslanatation and malignancy
 
7. immunodeficiency syndromes
7. immunodeficiency syndromes7. immunodeficiency syndromes
7. immunodeficiency syndromes
 
Immunopathology lecture 2+3 ,final
Immunopathology lecture 2+3 ,finalImmunopathology lecture 2+3 ,final
Immunopathology lecture 2+3 ,final
 
Autoimmunity and autoimmune disease
Autoimmunity and autoimmune diseaseAutoimmunity and autoimmune disease
Autoimmunity and autoimmune disease
 
Tumor immunology
Tumor immunologyTumor immunology
Tumor immunology
 

Viewers also liked

Ch17 transplant immunology (2)
Ch17 transplant immunology (2)Ch17 transplant immunology (2)
Ch17 transplant immunology (2)Shabab Ali
 
Ch14 autoimmunity (4)
Ch14 autoimmunity (4)Ch14 autoimmunity (4)
Ch14 autoimmunity (4)Shabab Ali
 
Ch 18 tumor immunology
Ch 18 tumor immunologyCh 18 tumor immunology
Ch 18 tumor immunologyShabab Ali
 
Preanalytical variables in coagulation testing
Preanalytical variables in coagulation testingPreanalytical variables in coagulation testing
Preanalytical variables in coagulation testingShabab Ali
 
Chap20 Immunology & Serology
Chap20 Immunology & SerologyChap20 Immunology & Serology
Chap20 Immunology & SerologyAnalin Empaynado
 
Lecture 9, fall 2014
Lecture 9, fall 2014Lecture 9, fall 2014
Lecture 9, fall 2014Shabab Ali
 
Agglutination lecture
Agglutination lectureAgglutination lecture
Agglutination lecturerubina1000
 
L owen resilient short food chains cafs uk
L owen resilient short food chains cafs ukL owen resilient short food chains cafs uk
L owen resilient short food chains cafs ukJoy Elliott
 
Give peace a chance
Give peace a chanceGive peace a chance
Give peace a chanceelharala
 

Viewers also liked (20)

Ch08
Ch08Ch08
Ch08
 
Ch04
Ch04Ch04
Ch04
 
Ch10 (5)
Ch10 (5)Ch10 (5)
Ch10 (5)
 
Ch13 (3)
Ch13 (3)Ch13 (3)
Ch13 (3)
 
Ch09
Ch09Ch09
Ch09
 
Ch17 transplant immunology (2)
Ch17 transplant immunology (2)Ch17 transplant immunology (2)
Ch17 transplant immunology (2)
 
Ch14 autoimmunity (4)
Ch14 autoimmunity (4)Ch14 autoimmunity (4)
Ch14 autoimmunity (4)
 
Ch06
Ch06Ch06
Ch06
 
Ch 18 tumor immunology
Ch 18 tumor immunologyCh 18 tumor immunology
Ch 18 tumor immunology
 
Ch09 (2)
Ch09 (2)Ch09 (2)
Ch09 (2)
 
Preanalytical variables in coagulation testing
Preanalytical variables in coagulation testingPreanalytical variables in coagulation testing
Preanalytical variables in coagulation testing
 
Chap20 Immunology & Serology
Chap20 Immunology & SerologyChap20 Immunology & Serology
Chap20 Immunology & Serology
 
Ch02
Ch02Ch02
Ch02
 
Lecture 9, fall 2014
Lecture 9, fall 2014Lecture 9, fall 2014
Lecture 9, fall 2014
 
Agglutination lecture
Agglutination lectureAgglutination lecture
Agglutination lecture
 
family
familyfamily
family
 
L owen resilient short food chains cafs uk
L owen resilient short food chains cafs ukL owen resilient short food chains cafs uk
L owen resilient short food chains cafs uk
 
Give peace a chance
Give peace a chanceGive peace a chance
Give peace a chance
 
Delph (1)
Delph (1)Delph (1)
Delph (1)
 
Sunu
SunuSunu
Sunu
 

Similar to Ch16 (3)

immunodeficiency for mbbs students to ace in pathology
immunodeficiency for mbbs students to ace in pathologyimmunodeficiency for mbbs students to ace in pathology
immunodeficiency for mbbs students to ace in pathologymakesharumugam23
 
Primary immunodeficiency diseases by dr.gobinda
Primary immunodeficiency diseases by dr.gobindaPrimary immunodeficiency diseases by dr.gobinda
Primary immunodeficiency diseases by dr.gobindaGOBINDA PRASAD PRADHAN
 
Immunodeficiency Syndrome
Immunodeficiency SyndromeImmunodeficiency Syndrome
Immunodeficiency SyndromeHadi Munib
 
immunodeficiencyppt-170409084703.pptx
immunodeficiencyppt-170409084703.pptximmunodeficiencyppt-170409084703.pptx
immunodeficiencyppt-170409084703.pptxNadiirMahamoud
 
Immunodeficiency disease by Dr. Rakesh Prasad Sah
Immunodeficiency disease by Dr. Rakesh Prasad SahImmunodeficiency disease by Dr. Rakesh Prasad Sah
Immunodeficiency disease by Dr. Rakesh Prasad SahDr. Rakesh Prasad Sah
 
Immunodeficiency_Huwainan.pptx
Immunodeficiency_Huwainan.pptxImmunodeficiency_Huwainan.pptx
Immunodeficiency_Huwainan.pptxRizkaDeftiani1
 
G.2014-immuno~ (15.immunodeficiency diseases-xm)
 G.2014-immuno~ (15.immunodeficiency diseases-xm) G.2014-immuno~ (15.immunodeficiency diseases-xm)
G.2014-immuno~ (15.immunodeficiency diseases-xm)Helder Jorge Semedo Pires
 
COMMON VARIABLE IMMUNODEFICIENCY (CVID)
COMMON VARIABLE IMMUNODEFICIENCY (CVID)COMMON VARIABLE IMMUNODEFICIENCY (CVID)
COMMON VARIABLE IMMUNODEFICIENCY (CVID)Abdullatif Al-Rashed
 
Immunodeficiency_DISORDERS.pptx.........
Immunodeficiency_DISORDERS.pptx.........Immunodeficiency_DISORDERS.pptx.........
Immunodeficiency_DISORDERS.pptx.........samwel18
 
Draz MY Egypt COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIA
Draz  MY  Egypt COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIADraz  MY  Egypt COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIA
Draz MY Egypt COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIAmahmoodyasin
 
Draz MY Egypt COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIA
Draz  MY  Egypt COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIADraz  MY  Egypt COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIA
Draz MY Egypt COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIAmahmoodyasin
 
COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIA
COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIACOMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIA
COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIAmahmoodyasin
 
Immunodeficiency - SCID & LAD
Immunodeficiency - SCID & LADImmunodeficiency - SCID & LAD
Immunodeficiency - SCID & LADApoorva Rajagopal
 
Cytotoxic reaction
Cytotoxic reactionCytotoxic reaction
Cytotoxic reactionVISHAL VERMA
 
IMMUNODEFICIENCY IN HAEMATOLOGY
IMMUNODEFICIENCY IN HAEMATOLOGYIMMUNODEFICIENCY IN HAEMATOLOGY
IMMUNODEFICIENCY IN HAEMATOLOGYEbiweni Lokoja
 

Similar to Ch16 (3) (20)

Immunopathology 4
Immunopathology 4Immunopathology 4
Immunopathology 4
 
immunodeficiency for mbbs students to ace in pathology
immunodeficiency for mbbs students to ace in pathologyimmunodeficiency for mbbs students to ace in pathology
immunodeficiency for mbbs students to ace in pathology
 
Primary immunodeficiency diseases by dr.gobinda
Primary immunodeficiency diseases by dr.gobindaPrimary immunodeficiency diseases by dr.gobinda
Primary immunodeficiency diseases by dr.gobinda
 
Immunodeficiency diseases
Immunodeficiency diseasesImmunodeficiency diseases
Immunodeficiency diseases
 
Immunodeficiency Syndrome
Immunodeficiency SyndromeImmunodeficiency Syndrome
Immunodeficiency Syndrome
 
immunodeficiencyppt-170409084703.pptx
immunodeficiencyppt-170409084703.pptximmunodeficiencyppt-170409084703.pptx
immunodeficiencyppt-170409084703.pptx
 
Immunodeficiency disease by Dr. Rakesh Prasad Sah
Immunodeficiency disease by Dr. Rakesh Prasad SahImmunodeficiency disease by Dr. Rakesh Prasad Sah
Immunodeficiency disease by Dr. Rakesh Prasad Sah
 
Immunodeficiency_Huwainan.pptx
Immunodeficiency_Huwainan.pptxImmunodeficiency_Huwainan.pptx
Immunodeficiency_Huwainan.pptx
 
G.2014-immuno~ (15.immunodeficiency diseases-xm)
 G.2014-immuno~ (15.immunodeficiency diseases-xm) G.2014-immuno~ (15.immunodeficiency diseases-xm)
G.2014-immuno~ (15.immunodeficiency diseases-xm)
 
COMMON VARIABLE IMMUNODEFICIENCY (CVID)
COMMON VARIABLE IMMUNODEFICIENCY (CVID)COMMON VARIABLE IMMUNODEFICIENCY (CVID)
COMMON VARIABLE IMMUNODEFICIENCY (CVID)
 
Immunodeficiency_DISORDERS.pptx.........
Immunodeficiency_DISORDERS.pptx.........Immunodeficiency_DISORDERS.pptx.........
Immunodeficiency_DISORDERS.pptx.........
 
Draz MY Egypt COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIA
Draz  MY  Egypt COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIADraz  MY  Egypt COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIA
Draz MY Egypt COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIA
 
Draz MY Egypt COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIA
Draz  MY  Egypt COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIADraz  MY  Egypt COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIA
Draz MY Egypt COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIA
 
COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIA
COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIACOMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIA
COMMON VARIABLE IMMUNODEFICIENCYP,PID,HYPOGAMMAGLOBULINEMIA
 
Immunodeficiency - SCID & LAD
Immunodeficiency - SCID & LADImmunodeficiency - SCID & LAD
Immunodeficiency - SCID & LAD
 
Cytotoxic reaction
Cytotoxic reactionCytotoxic reaction
Cytotoxic reaction
 
IMMUNODEFICIENCY IN HAEMATOLOGY
IMMUNODEFICIENCY IN HAEMATOLOGYIMMUNODEFICIENCY IN HAEMATOLOGY
IMMUNODEFICIENCY IN HAEMATOLOGY
 
Immunodeficiency ppt
Immunodeficiency pptImmunodeficiency ppt
Immunodeficiency ppt
 
Hyper Ig M syndrome
Hyper Ig M syndromeHyper Ig M syndrome
Hyper Ig M syndrome
 
Immunodeficiency
ImmunodeficiencyImmunodeficiency
Immunodeficiency
 

More from Shabab Ali

Overview of platelet physiology
Overview of platelet physiologyOverview of platelet physiology
Overview of platelet physiologyShabab Ali
 
Lecture 8, fall 2014
Lecture 8, fall 2014Lecture 8, fall 2014
Lecture 8, fall 2014Shabab Ali
 
Lecture 7, fall 2014
Lecture 7, fall 2014Lecture 7, fall 2014
Lecture 7, fall 2014Shabab Ali
 
Lecture 6, coagulation fall 2014
Lecture 6, coagulation fall 2014Lecture 6, coagulation fall 2014
Lecture 6, coagulation fall 2014Shabab Ali
 
Lecture 5, part 2 fall 2014
Lecture 5, part 2 fall 2014Lecture 5, part 2 fall 2014
Lecture 5, part 2 fall 2014Shabab Ali
 
Lecture 5, fall 2014 pdf
Lecture 5, fall 2014 pdfLecture 5, fall 2014 pdf
Lecture 5, fall 2014 pdfShabab Ali
 
Lecture 4, fall 2014 pdf
Lecture 4, fall 2014 pdfLecture 4, fall 2014 pdf
Lecture 4, fall 2014 pdfShabab Ali
 
Lecture 3, spring 2014
Lecture 3, spring 2014Lecture 3, spring 2014
Lecture 3, spring 2014Shabab Ali
 
Lecture 2, fall 2014 pdf
Lecture 2, fall 2014 pdfLecture 2, fall 2014 pdf
Lecture 2, fall 2014 pdfShabab Ali
 
Lecture 1, fall 2014
Lecture 1, fall 2014Lecture 1, fall 2014
Lecture 1, fall 2014Shabab Ali
 
Lab parasites sections 1 xbc-!xcs
Lab parasites   sections 1 xbc-!xcsLab parasites   sections 1 xbc-!xcs
Lab parasites sections 1 xbc-!xcsShabab Ali
 
Colonial morphology
Colonial morphologyColonial morphology
Colonial morphologyShabab Ali
 
Bio265 lab 6 1 xbc and 1xcs _dr di bonaventura
Bio265 lab 6  1 xbc and 1xcs _dr di bonaventuraBio265 lab 6  1 xbc and 1xcs _dr di bonaventura
Bio265 lab 6 1 xbc and 1xcs _dr di bonaventuraShabab Ali
 
13 bio265 disease of gastrointestinal, urogenital systems instructor dr di bo...
13 bio265 disease of gastrointestinal, urogenital systems instructor dr di bo...13 bio265 disease of gastrointestinal, urogenital systems instructor dr di bo...
13 bio265 disease of gastrointestinal, urogenital systems instructor dr di bo...Shabab Ali
 
12 bio265 disease of circulatory system instructor dr di bonaventura
12 bio265 disease of circulatory system instructor dr di bonaventura12 bio265 disease of circulatory system instructor dr di bonaventura
12 bio265 disease of circulatory system instructor dr di bonaventuraShabab Ali
 
11 bio265 disease of respiratory system instructor dr di bonaventura
11 bio265 disease of respiratory system instructor dr di bonaventura11 bio265 disease of respiratory system instructor dr di bonaventura
11 bio265 disease of respiratory system instructor dr di bonaventuraShabab Ali
 
10 bio265 disease of skin and cns instructor dr di bonaventura
10 bio265 disease of skin and cns instructor dr di bonaventura10 bio265 disease of skin and cns instructor dr di bonaventura
10 bio265 disease of skin and cns instructor dr di bonaventuraShabab Ali
 
9 bio265 viruses, fungi, protozoa, helminths instructor dr di bonaventura
9 bio265 viruses, fungi, protozoa, helminths instructor dr di bonaventura9 bio265 viruses, fungi, protozoa, helminths instructor dr di bonaventura
9 bio265 viruses, fungi, protozoa, helminths instructor dr di bonaventuraShabab Ali
 
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventuraShabab Ali
 
8 bio265 microbiology and immunology 1 instructor dr di bonaventura
8 bio265 microbiology and immunology 1 instructor dr di bonaventura8 bio265 microbiology and immunology 1 instructor dr di bonaventura
8 bio265 microbiology and immunology 1 instructor dr di bonaventuraShabab Ali
 

More from Shabab Ali (20)

Overview of platelet physiology
Overview of platelet physiologyOverview of platelet physiology
Overview of platelet physiology
 
Lecture 8, fall 2014
Lecture 8, fall 2014Lecture 8, fall 2014
Lecture 8, fall 2014
 
Lecture 7, fall 2014
Lecture 7, fall 2014Lecture 7, fall 2014
Lecture 7, fall 2014
 
Lecture 6, coagulation fall 2014
Lecture 6, coagulation fall 2014Lecture 6, coagulation fall 2014
Lecture 6, coagulation fall 2014
 
Lecture 5, part 2 fall 2014
Lecture 5, part 2 fall 2014Lecture 5, part 2 fall 2014
Lecture 5, part 2 fall 2014
 
Lecture 5, fall 2014 pdf
Lecture 5, fall 2014 pdfLecture 5, fall 2014 pdf
Lecture 5, fall 2014 pdf
 
Lecture 4, fall 2014 pdf
Lecture 4, fall 2014 pdfLecture 4, fall 2014 pdf
Lecture 4, fall 2014 pdf
 
Lecture 3, spring 2014
Lecture 3, spring 2014Lecture 3, spring 2014
Lecture 3, spring 2014
 
Lecture 2, fall 2014 pdf
Lecture 2, fall 2014 pdfLecture 2, fall 2014 pdf
Lecture 2, fall 2014 pdf
 
Lecture 1, fall 2014
Lecture 1, fall 2014Lecture 1, fall 2014
Lecture 1, fall 2014
 
Lab parasites sections 1 xbc-!xcs
Lab parasites   sections 1 xbc-!xcsLab parasites   sections 1 xbc-!xcs
Lab parasites sections 1 xbc-!xcs
 
Colonial morphology
Colonial morphologyColonial morphology
Colonial morphology
 
Bio265 lab 6 1 xbc and 1xcs _dr di bonaventura
Bio265 lab 6  1 xbc and 1xcs _dr di bonaventuraBio265 lab 6  1 xbc and 1xcs _dr di bonaventura
Bio265 lab 6 1 xbc and 1xcs _dr di bonaventura
 
13 bio265 disease of gastrointestinal, urogenital systems instructor dr di bo...
13 bio265 disease of gastrointestinal, urogenital systems instructor dr di bo...13 bio265 disease of gastrointestinal, urogenital systems instructor dr di bo...
13 bio265 disease of gastrointestinal, urogenital systems instructor dr di bo...
 
12 bio265 disease of circulatory system instructor dr di bonaventura
12 bio265 disease of circulatory system instructor dr di bonaventura12 bio265 disease of circulatory system instructor dr di bonaventura
12 bio265 disease of circulatory system instructor dr di bonaventura
 
11 bio265 disease of respiratory system instructor dr di bonaventura
11 bio265 disease of respiratory system instructor dr di bonaventura11 bio265 disease of respiratory system instructor dr di bonaventura
11 bio265 disease of respiratory system instructor dr di bonaventura
 
10 bio265 disease of skin and cns instructor dr di bonaventura
10 bio265 disease of skin and cns instructor dr di bonaventura10 bio265 disease of skin and cns instructor dr di bonaventura
10 bio265 disease of skin and cns instructor dr di bonaventura
 
9 bio265 viruses, fungi, protozoa, helminths instructor dr di bonaventura
9 bio265 viruses, fungi, protozoa, helminths instructor dr di bonaventura9 bio265 viruses, fungi, protozoa, helminths instructor dr di bonaventura
9 bio265 viruses, fungi, protozoa, helminths instructor dr di bonaventura
 
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
8 2 bio265 microbiology and immunology_2 instructor dr di bonaventura
 
8 bio265 microbiology and immunology 1 instructor dr di bonaventura
8 bio265 microbiology and immunology 1 instructor dr di bonaventura8 bio265 microbiology and immunology 1 instructor dr di bonaventura
8 bio265 microbiology and immunology 1 instructor dr di bonaventura
 

Recently uploaded

TOPIC 8 Temperature and Heat.pdf physics
TOPIC 8 Temperature and Heat.pdf physicsTOPIC 8 Temperature and Heat.pdf physics
TOPIC 8 Temperature and Heat.pdf physicsssuserddc89b
 
Speech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptxSpeech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptxpriyankatabhane
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Patrick Diehl
 
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.PraveenaKalaiselvan1
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real timeSatoshi NAKAHIRA
 
Solution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutionsSolution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutionsHajira Mahmood
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxSwapnil Therkar
 
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdfBUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdfWildaNurAmalia2
 
Microteaching on terms used in filtration .Pharmaceutical Engineering
Microteaching on terms used in filtration .Pharmaceutical EngineeringMicroteaching on terms used in filtration .Pharmaceutical Engineering
Microteaching on terms used in filtration .Pharmaceutical EngineeringPrajakta Shinde
 
Transposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.pptTransposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.pptArshadWarsi13
 
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPirithiRaju
 
Neurodevelopmental disorders according to the dsm 5 tr
Neurodevelopmental disorders according to the dsm 5 trNeurodevelopmental disorders according to the dsm 5 tr
Neurodevelopmental disorders according to the dsm 5 trssuser06f238
 
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...lizamodels9
 
GenBio2 - Lesson 1 - Introduction to Genetics.pptx
GenBio2 - Lesson 1 - Introduction to Genetics.pptxGenBio2 - Lesson 1 - Introduction to Genetics.pptx
GenBio2 - Lesson 1 - Introduction to Genetics.pptxBerniceCayabyab1
 
Davis plaque method.pptx recombinant DNA technology
Davis plaque method.pptx recombinant DNA technologyDavis plaque method.pptx recombinant DNA technology
Davis plaque method.pptx recombinant DNA technologycaarthichand2003
 
FREE NURSING BUNDLE FOR NURSES.PDF by na
FREE NURSING BUNDLE FOR NURSES.PDF by naFREE NURSING BUNDLE FOR NURSES.PDF by na
FREE NURSING BUNDLE FOR NURSES.PDF by naJASISJULIANOELYNV
 
Pests of jatropha_Bionomics_identification_Dr.UPR.pdf
Pests of jatropha_Bionomics_identification_Dr.UPR.pdfPests of jatropha_Bionomics_identification_Dr.UPR.pdf
Pests of jatropha_Bionomics_identification_Dr.UPR.pdfPirithiRaju
 
Scheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxScheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxyaramohamed343013
 
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptx
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptxTHE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptx
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptxNandakishor Bhaurao Deshmukh
 

Recently uploaded (20)

Volatile Oils Pharmacognosy And Phytochemistry -I
Volatile Oils Pharmacognosy And Phytochemistry -IVolatile Oils Pharmacognosy And Phytochemistry -I
Volatile Oils Pharmacognosy And Phytochemistry -I
 
TOPIC 8 Temperature and Heat.pdf physics
TOPIC 8 Temperature and Heat.pdf physicsTOPIC 8 Temperature and Heat.pdf physics
TOPIC 8 Temperature and Heat.pdf physics
 
Speech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptxSpeech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptx
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?
 
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real time
 
Solution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutionsSolution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutions
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
 
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdfBUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
 
Microteaching on terms used in filtration .Pharmaceutical Engineering
Microteaching on terms used in filtration .Pharmaceutical EngineeringMicroteaching on terms used in filtration .Pharmaceutical Engineering
Microteaching on terms used in filtration .Pharmaceutical Engineering
 
Transposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.pptTransposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.ppt
 
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
 
Neurodevelopmental disorders according to the dsm 5 tr
Neurodevelopmental disorders according to the dsm 5 trNeurodevelopmental disorders according to the dsm 5 tr
Neurodevelopmental disorders according to the dsm 5 tr
 
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
 
GenBio2 - Lesson 1 - Introduction to Genetics.pptx
GenBio2 - Lesson 1 - Introduction to Genetics.pptxGenBio2 - Lesson 1 - Introduction to Genetics.pptx
GenBio2 - Lesson 1 - Introduction to Genetics.pptx
 
Davis plaque method.pptx recombinant DNA technology
Davis plaque method.pptx recombinant DNA technologyDavis plaque method.pptx recombinant DNA technology
Davis plaque method.pptx recombinant DNA technology
 
FREE NURSING BUNDLE FOR NURSES.PDF by na
FREE NURSING BUNDLE FOR NURSES.PDF by naFREE NURSING BUNDLE FOR NURSES.PDF by na
FREE NURSING BUNDLE FOR NURSES.PDF by na
 
Pests of jatropha_Bionomics_identification_Dr.UPR.pdf
Pests of jatropha_Bionomics_identification_Dr.UPR.pdfPests of jatropha_Bionomics_identification_Dr.UPR.pdf
Pests of jatropha_Bionomics_identification_Dr.UPR.pdf
 
Scheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxScheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docx
 
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptx
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptxTHE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptx
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptx
 

Ch16 (3)

  • 1. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis CompanyCopyright © 2010 F.A. Davis Company Immunodeficiency Diseases Chapter Sixteen
  • 2. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases Figure 16-1
  • 3. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases  Because the components of the humoral and cell-mediated portions of the immune system interact extensively through many regulatory and effector loops, a defect in one arm of the system may affect other aspects of immune function as well.  With the exception of IgA deficiency, primary immunodeficiency syndromes are rare.
  • 4. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases  A deficiency of one component of the system is often accompanied by hyperactivity of other component, including allergic or autoimmune manifestations.  More than 120 different congenital forms of immunodeficiency have been reported, including defects in lymphoid cells, phagocytic cells, and complement proteins. Some are X-linked; some are autosomal recessive. When NK cells are reduced, there is a higher rate of malignancy.
  • 5. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases  The clinical symptoms associated with immune deficiencies range from very mild or subclinical to severe recurrent infections or failure to thrive.  In general, defects in humoral immunity result in pyogenic bacterial infections, particularly of the upper and lower respiratory tract.  Complement deficiencies result in recurrent bacterial infections and autoimmune problems.
  • 6. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases  Defects in T-cell-mediated immunity result in recurrent infections with intracellular pathogens such as viruses, fungi, and intracellular bacteria.  These patients are also prone to disseminated viral infections, especially with latent viruses such as herpes simplex, varicella zoster, and cytomegalovirus.
  • 7. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases  The mechanisms of the agammaglobulinemias include genetic defects in B-cell maturation or mutations leading to defective interactions between B and T cells.  Only the more common and well-characterized syndromes are described here and are summarized in Table 16-1.
  • 8. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases  In evaluating immunoglobulin deficiency states, it is important to remember that blood levels of immunoglobulins change with age.  IgM reaches normal adult levels first, around 1 year of age, followed by IgG at about 5 to 6 years of age.  In some normal children, IgA levels do not reach normal adult values until adolescence.
  • 9. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases – THI  All infants experience low levels of immunoglobulins at approximately 5 to 6 months of age, but in some cases, the low levels persist for a longer time.  Transient hypogammaglobulinemia of infancy may result.  The mechanism of this transient hypogammaglobulinemia is not known.
  • 10. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases – BA  Bruton’s agammaglobulinemia, first described in 1952, is X chromosome–linked, and so affects males almost exclusively.  Patients with X-linked agammaglobulinemia lack circulating mature CD19 positive B cells and exhibit a deficiency or lack of immunoglobulins of all classes.
  • 11. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases – BA  Patients have no plasma cells in their lymphoid tissues, but they do have pre-B cells in their bone marrow.  T cells are normal in number and function.  These patients develop recurrent bacterial infections beginning in infancy, as maternal antibody is cleared.
  • 12. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases – BA  X-linked hypogammaglobulinemia results from arrested differentiation at the pre-B cell stage, leading to a complete absence of mature B cells and plasma cells.  The underlying genetic mechanism is a deficiency of an enzyme called the Bruton tyrosine kinase (Btk) in B-cell progenitor cells.
  • 13. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases – BA  Lack of the Btk enzyme apparently causes a failure of Vh gene rearrangement.  The syndrome can be differentiated from transient hypogammaglobulinemia of infancy by the absence of CD19 positive B cells in the peripheral blood, by the abnormal histology of lymphoid tissues, and by its persistence beyond 2 years of age.
  • 14. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases – IgA Def  Most patients with IgA deficiency are asymptomatic. This is the most common congenital immune deficiency and appears to be a failure in isotype switching in B cells.  Those patients with symptoms usually have infections of the respiratory and gastrointestinal tract and an increased tendency to autoimmune diseases and allergies
  • 15. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases – CVI  Common variable immunodeficiency (CVI) is a heterogeneous group of disorders , leading to IgG and IgA deficiencies  The disorder can be congenital or acquired, familial or sporadic, and it occurs with equal frequency in men and women.  leads to recurrent bacterial infections, particularly sinusitis and pneumonia.
  • 16. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases – CVI  In contrast to X-linked agammaglobulinemia, most patients with CVI have normal numbers of mature B cells, but they fail to transform into plasma cells.
  • 17. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases  Defects in cell-mediated immunity can result from abnormalities at many different stages of T-cell development.  In some cases, a primary defect in cell- mediated immunity can also have secondary effects on humoral immunity.
  • 18. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases – DGA  The immunodeficiency associated with the DiGeorge anomaly is a quantitative defect in thymocytes due to a developmental defect in the thymus.  Insufficient mature T cells are made, but those that are present are functionally normal. May undergo bone marrow or thymus transplant.
  • 19. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases  Defects in both humoral (B cell) and cell- mediated (T cell) immunity can be caused by a defect that affects development of both types of lymphocytes or a defective interaction between the two limbs of the immune system.
  • 20. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases – SCID  The most serious of the congenital immune deficiencies is severe combined immunodeficiency (SCID).  SCID is actually a group of related diseases that all affect T- and B-cell function but with differing causes.  X-linked SCID is the most common form of the disease, presenting in early infancy with multiple types of infections.
  • 21. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases – SCID  The abnormal gene involved codes for a protein chain called the common gamma chain, which is common to receptors for interleukins 2, 4, 7, 9, 15, and 21.  The gene is referred to as the IL2RG gene and is located on the X chromosome.  Normal signaling cannot occur in cells with defective receptors, thus halting proliferation and maturation.
  • 22. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases  Chronic granulomatous disease (CGD) is a group of disorders inherited as either an X- linked or autosomal recessive gene that affects neutrophil microbicidal function.  X-linked disease accounts for 70 percent of the cases, and it tends to be more severe.  CGD is the most common and best characterized of the neutrophil abnormalities.
  • 23. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases – CGD  There are three different autosomal recessive genes involved, and all of these affect subunits of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase.  Normally, neutrophil stimulation leads to the production of reactive oxygen molecules, such as hydrogen peroxide (H2O2), by NADPH oxidase on the plasma membrane.
  • 24. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases – CGD  Neutrophil granules fuse with, and release their contents into, the forming phagosome, as organisms are phagocytized.  Hydrogen peroxide is then used by the granule enzyme myeloperoxidase to generate the potent microbicidal agent hypochlorous acid.  In CGD, neutrophils are unable to undergo the oxidative burst.
  • 25. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases – CGD  CGD was historically diagnosed by measuring the ability of a patient’s neutrophils to reduce the dye nitro-blue tetrazolium (NBT).  More recently, a flow cytometric assay has become available.  Patients have a deficiency in G6PD for hydrogen peroxide production, or myeloperoxidase activity for hypochlorite production
  • 26. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases – NGDD  Even if microbicidal activity is normal, neutrophils cannot perform their functions properly if they fail to leave the vasculature and migrate to a site of incipient infection.  Adhesion receptors on leukocytes (integrins) and their counter-receptors on endothelial cells (selectins) and extracellular matrix play important roles in these activities.
  • 27. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases  In leukocyte adhesion deficiency (LAD), a protein (CD18) that is a component of adhesion receptors on neutrophils and monocytes (with CD11b or CD11c) and on T cells (with CD11a) is defective.  This defect leads to abnormal adhesion, motility, aggregation, chemotaxis, and endocytosis by the affected leukocytes.
  • 28. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Diseases – LAD  The defects are clinically manifested as delayed wound healing, chronic skin infections, intestinal and respiratory tract infections, and periodontitis.  A defect in CD18 can be diagnosed by detecting a decreased amount of the CD11/18 antigen on patient leukocytes by flow cytometry.
  • 29. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Disease  Deficiencies in each of the major complement components have been described, leading to various clinical sequelae.  Deficiencies in the early complement components, C1q, 4, and 2, are usually associated with a lupus-like syndrome.  Deficiency of C2 is believed to be the most common complement component deficiency.
  • 30. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Disease  A C3 deficiency may also have a lupus-like clinical presentation but is more likely to involve recurrent encapsulated organism infection.  Deficiencies of the later components of complement (C5–C9) are often associated with recurrent Neisseria meningitidis infections.
  • 31. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Disease  Screening tests used for the initial evaluation of suspected immunodeficiency states are summarized in Table 16-3.  Measurement of the levels of serum IgG, IgM, and IgA and levels of the subclasses of IgG are used to screen for defects in antibody production.
  • 32. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Disease  An overall assessment of antibody-mediated immunity can be made by measuring antibody responses to antigens to which the population is exposed normally or following vaccination.  Delayed-hypersensitivity-type skin reactions can be used to screen for defects in cell- mediated immunity.
  • 33. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Disease  Screening for complement deficiencies usually begins with a CH50 assay to determine the level of functional complement in an individual.  See Chapter 6 for details of the CH50 assay.  Defects in neutrophil oxidative burst activity may be detected by a flow cytometric assay, as mentioned earlier.
  • 34. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Disease  If the screening tests detect an abnormality or if the clinical suspicion is high, more specialized testing will probably be necessary to precisely identify an immune abnormality.  Some of the tests used for confirming an immunodeficiency state are summarized in Table 16-4.
  • 35. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Disease  Enumeration of classes of lymphocytes in the peripheral blood, bone marrow, and lymph nodes is performed by flow cytometry.  For example, an absence or profound decrease in the number of CD3 positive cells would be consistent with DiGeorge syndrome.  An absence of CD19 positive B cells suggests Bruton’s agammaglobulinemia.
  • 36. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Disease  Genetic testing is available for many conditions, including the DiGeorge deletion, the Wiskott-Aldrich gene, and the IL2RG mutations in SCID.  T-cell function can be measured by assessing the ability of isolated T cells to proliferate in response to an antigenic stimulus or to nonspecific mitogens in culture.
  • 37. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Disease  Quantitative measurement of serum or urine immunoglobulins by protein electrophoresis is used in the workup of both immunodeficiency states and some lymphoproliferative disorders.  Protein electrophoresis allows reproducible separation of the major plasma proteins (see Chapter 4 for details).
  • 38. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Disease  Additional evaluation of serum immunoglobulin is performed if the SPE shows a monoclonal component or if there is a significant quantitative abnormality of serum immunoglobulins.  Another method of characterizing immune deficiencies is immunofixation electrophoresis (IFE).
  • 39. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Disease  Polyclonal immunoglobulins are indicated by areas of diffuse staining, while monoclonal bands produce narrow, intensely stained bands.  Lack of bands indicates immunodeficiencies of one or more immunoglobulin classes.  Refer to Figure 15-2 in Chapter 15 for details regarding immunofixation.  See Figure 16-2 for further examples of IF.
  • 40. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Disease Figure 16-2
  • 41. Clinical Immunology & Serology A Laboratory Perspective, Third Edition Copyright © 2010 F.A. Davis Company Immunodeficiency Disease  Specific immunoglobulin isotype levels can be determined by nephelometry.  A bone marrow aspirate and biopsy is indicated in any evaluation of monoclonal gammopathy or immunodeficiency state.